Purpose The partial saturation approach (PSA) is a simple, single injection experimental protocol that will estimate both Bavail and appKD without the use of blood sampling. This makes it ideal for use in longitudinal studies of neurodegenerative diseases in the rodent. The aim of this study was to increase the range and applicability of the PSA by developing a data driven strategy for determining reliable regional estimates of receptor density (Bavail) and in vivo affinity (1/appKD), and validate the strategy using a simulation model. Methods The data driven method uses a time window guided by the dynamic equilibrium state of the system as opposed to using a static time window. To test the method, simulations of partial saturation experime...
PURPOSE: This study evaluates the performance of several parametric methods for assessing [11C]fluma...
When building the novel public mammalian toxicokinetic database (MamTKDB) we collected and included ...
Parkinson’s disease (PD) is one of the most common neurodegenerative diseases worldwide. The use of ...
Positron emission tomography (PET) with [11C]Raclopride is an important tool for studying dopamine D...
International audienceLongitudinal mouse PET imaging is becoming increasingly popular due to the lar...
Receptor occupancy assessed by Positron Emission Tomography (PET) can provide important translationa...
Molecular imaging of the D2/3 receptor is widely used in neuropsychiatric research. Non-displaceable...
Purpose: Changes in GABAA-receptor density and affinity play an important role in many forms of epil...
Cutamesine (SA4503) is a selective sigma-1 receptor agonist, currently in Phase II clinical trials f...
Central substance P receptors, termed NK-1 receptors, have been considered as therapeutic targets in...
The reference tissue model allows for quantification of receptor kinetics without measuring the arte...
In vivo imaging for the A1 adenosine receptors (A1ARs) with positron emission tomography (PET) using...
This thesis investigates quantitative methods for the characterisation of dopamine (DA) release in p...
Positron emission tomography (PET) with [11C]raclopride is widely used to investigate temporal chang...
Physiologically-based kinetic (PBK) models can simulate concentrations of chemicals in tissues over ...
PURPOSE: This study evaluates the performance of several parametric methods for assessing [11C]fluma...
When building the novel public mammalian toxicokinetic database (MamTKDB) we collected and included ...
Parkinson’s disease (PD) is one of the most common neurodegenerative diseases worldwide. The use of ...
Positron emission tomography (PET) with [11C]Raclopride is an important tool for studying dopamine D...
International audienceLongitudinal mouse PET imaging is becoming increasingly popular due to the lar...
Receptor occupancy assessed by Positron Emission Tomography (PET) can provide important translationa...
Molecular imaging of the D2/3 receptor is widely used in neuropsychiatric research. Non-displaceable...
Purpose: Changes in GABAA-receptor density and affinity play an important role in many forms of epil...
Cutamesine (SA4503) is a selective sigma-1 receptor agonist, currently in Phase II clinical trials f...
Central substance P receptors, termed NK-1 receptors, have been considered as therapeutic targets in...
The reference tissue model allows for quantification of receptor kinetics without measuring the arte...
In vivo imaging for the A1 adenosine receptors (A1ARs) with positron emission tomography (PET) using...
This thesis investigates quantitative methods for the characterisation of dopamine (DA) release in p...
Positron emission tomography (PET) with [11C]raclopride is widely used to investigate temporal chang...
Physiologically-based kinetic (PBK) models can simulate concentrations of chemicals in tissues over ...
PURPOSE: This study evaluates the performance of several parametric methods for assessing [11C]fluma...
When building the novel public mammalian toxicokinetic database (MamTKDB) we collected and included ...
Parkinson’s disease (PD) is one of the most common neurodegenerative diseases worldwide. The use of ...